Antimicrobial Resistance (AMR)
The "Antimicrobial Resistance (AMR)" track at the Vaccines World 2025 conference addresses one of the most pressing global health challenges. We invite researchers to submit abstracts that explore innovative approaches to combating AMR, including the development of novel vaccines and therapeutic strategies to counteract resistant pathogens.
What to Expect: Attendees will gain insights into the latest research on AMR, including emerging resistance mechanisms and their impact on public health. The track will feature presentations on vaccine strategies designed to prevent infections caused by resistant bacteria and other pathogens. Discussions will also cover advancements in diagnostics, surveillance, and the integration of new technologies to address AMR. Interactive sessions will foster collaborations and provide opportunities to explore practical solutions and policy implications related to antimicrobial resistance.
Join us to be at the forefront of the fight against AMR, share your research, and collaborate on innovative solutions to safeguard global health against resistant infections.
Related Conference of Antimicrobial Resistance (AMR)
9th International Conference on Vaccines, Immunology and Clinical Trials
7th International conference on Vaccines, Vaccination and Immunization
Antimicrobial Resistance (AMR) Conference Speakers
Recommended Sessions
- DNA-RNA Vaccines
- Vaccine Production, Supply & Logistics
- Vaccine Research and Development
- Antimicrobial Resistance (AMR)
- Bioprocessing and Manufacturing
- Cancer Vaccines and Immunotherapy
- Clinical Trials
- Conjugate Vaccine
- Coronavirus (COVID-19) & Pandemic Vaccines
- Emerging and Re-Emerging Diseases
- Fungal/Bacterial/Viral/Parasitic/STD Vaccines
- HIV Vaccines
- Immune Profiling
- Infectious and Non-Infectious Diseases
- Influenza and Respiratory Vaccines
- Thermo Stabilized Vaccines
- Vaccine Adjuvants
- Vaccine Safety, Efficacy & Regulatory Affairs
- Veterinary Vaccine
Related Journals
Are you interested in
- Advancements in Vaccine Research and Development - Vaccines R&D 2026 (France)
- Advances in Pediatric Vaccines - Vaccines R&D 2026 (France)
- Animal & Plant Derived Vaccines - Vaccines-Immunization-2026 (France)
- Animal Models & Clinical Trials - Vaccines-Immunization-2026 (France)
- Antibodies: Engineering & Therapeutics - Vaccines-Immunization-2026 (France)
- Cancer, Malaria & TB Vaccines - Vaccines-Immunization-2026 (France)
- Cellular Immunology & Latest Innovations - Vaccines-Immunization-2026 (France)
- Clinical Trials Design and Methodologies - Vaccines R&D 2026 (France)
- Combination & Conjugate Vaccines - Vaccines-Immunization-2026 (France)
- Current Research & Future Challenges - Vaccines-Immunization-2026 (France)
- DNA & Synthetic Vaccines - Vaccines-Immunization-2026 (France)
- Emerging Infectious Diseases and Vaccine Development - Vaccines R&D 2026 (France)
- Ethical Considerations in Vaccine Development and Distribution - Vaccines R&D 2026 (France)
- Fish & Poultry Vaccines - Vaccines-Immunization-2026 (France)
- Geriatric Immunization - Vaccines-Immunization-2026 (France)
- Global Immunization Strategies and Policy - Vaccines R&D 2026 (France)
- HIV Vaccines - Vaccines-Immunization-2026 (France)
- Immunology of Infectious Diseases - Vaccines R&D 2026 (France)
- Immunotherapy and Personalized Medicine - Vaccines R&D 2026 (France)
- Innovations in Vaccine Cold Chain and Storage - Vaccines R&D 2026 (France)
- Paediatric Vaccination - Vaccines-Immunization-2026 (France)
- Regulatory Approaches in Vaccine Development - Vaccines R&D 2026 (France)
- Role of Adjuvants in Vaccine Efficacy - Vaccines R&D 2026 (France)
- Role of AI and Big Data in Vaccine Research - Vaccines R&D 2026 (France)
- Translational Immunology and Vaccine Development - Vaccines R&D 2026 (France)
- Travel & Edible Vaccines - Vaccines-Immunization-2026 (France)
- Vaccine Delivery Systems: Innovations and Challenges - Vaccines R&D 2026 (France)
- Vaccine Development for Cancer Immunotherapy - Vaccines R&D 2026 (France)
- Vaccine Development for Vector-Borne Diseases - Vaccines R&D 2026 (France)
- Vaccine Equity and Access in Low-Resource Settings - Vaccines R&D 2026 (France)
- Vaccine Hesitancy and Public Perception - Vaccines R&D 2026 (France)
- Vaccine Manufacturing and Distribution - Vaccines R&D 2026 (France)
- Vaccine Production & Development - Vaccines-Immunization-2026 (France)
- Vaccine Safety and Pharmacovigilance - Vaccines R&D 2026 (France)
- Vaccines - Vaccines-Immunization-2026 (France)
- Vaccines & Autism - Vaccines-Immunization-2026 (France)
- Vaccines against Drugs - Vaccines-Immunization-2026 (France)
- Vaccines against Infectious Diseases - Vaccines-Immunization-2026 (France)
- Vaccines for Immune Mediated Diseases - Vaccines-Immunization-2026 (France)
- Vaccines for Pregnant Women & Neonates - Vaccines-Immunization-2026 (France)
- Vaccines for Unconventional Diseases - Vaccines-Immunization-2026 (France)
- Vectors, Adjuvants & Delivery Systems - Vaccines-Immunization-2026 (France)

